Monogenic autoinflammatory diseases in children: single center experience with clinical, genetic, and imaging review
- PMID: 32737687
- PMCID: PMC7394994
- DOI: 10.1186/s13244-020-00889-0
Monogenic autoinflammatory diseases in children: single center experience with clinical, genetic, and imaging review
Abstract
Purpose: 1. To review the contemporary literature and present a list of the imaging findings for patients with autoinflammatory diseases from our hospital. All these patients are found to have a genetic mutation that is responsible for their disease. 2. To present follow-up imaging findings, when available, and correlate those with symptoms and type of treatment administered in approximately 40 patients with autoinflammatory diseases of a single tertiary pediatric health care center including familial Mediterranean fever, Cryopyrin-associated autoinflammatory syndrome, PAPA (pyogenic arthritis, pyoderma gangrenousum, and acne) syndrome, and more. These findings are related to disease progression, treatment response, or treatment-induced changes.
Conclusion: Autoinflammatory diseases are relatively rare entities that can affect any system of the body. Given the many nonspecific imaging features, awareness of these diseases and good communication with clinicians aid in reaching an accurate diagnosis.
Keywords: Autoinflammatory diseases; Children; Fever; Radiology; Rheumatology.
Conflict of interest statement
RL: Consultant to Sanofi, Eli Lilly, Novartis. Autoinflammatory Registry is funded by Novartis.
AD:
• Research Support: Bayer Healthcare Inc (Research Grant), Novo Nordisk Healthcare Inc (Research Grant), Terry Fox Foundation (Research Grant), Physician’s Services Incorporation (Research Grant)
• Advisory Committee: International Prophylaxis Study Group (not for profit). OMERACT SIG in MRI in JIA (not for profit), Canadian Committee of Point-of-Care Ultrasound (not for profit)
• Consultant: Baxter Healthcare Inc, Pfizer Healthcare Inc.
ANA, QW, JS, PB, CM: no competing interest.
Figures












References
-
- Ter Haar NM, Annink KV, Al-Mayouf SM, et al. Development of the autoinflammatory disease damage index (ADDI) Ann Rheum Dis. 2017;76(5):821–830. - PubMed
-
- Ozen S, Bilginer Y. A clinical guide to autoinflammatory diseases: familial Mediterranean fever and next-of-kin. Nat Rev Rheumatol. 2014;10(3):135. - PubMed
-
- Tunca M, Akar S, Onen F, et al. Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine (Baltimore). 2005;84(1):1–1. - PubMed
-
- Eshed I, Kushnir T, Livneh A, et al. Exertional leg pain as a manifestation of occult spondyloarthropathy in familial Mediterranean fever: an MRI evaluation. Scand J Rheumatol. 2012;41(6):482–486. - PubMed
Publication types
LinkOut - more resources
Full Text Sources